Search

Plastic surgery founding father Ivo Pitanguy on life, learning and legends – remembering a giant

World renowned Plastic Surgeon Ivo Pitanguy passed away on 6 August 2016 at the age of 93 just a day after carrying the Olympic torch for the Rio Games. Read on to learn about the life of this giant of...

Building sustainable global partnerships – the BFIRST perspective on future-proofing global plastic surgery

The British Foundation for International Surgery and Training (BFIRST) marks their 10-year anniversary this year as an organisation. As the international outreach arm of the British Association of Plastic, Reconstructive & Aesthetic Surgeons (BAPRAS), BFIRST focuses on supporting surgeons in...

Lymphoedema surgical treatment: myths and facts

Lymphoedema is a common condition that has a major impact on quality of life. Surgical treatment can help affected patients and produce good results, but there is no consensus on which surgical procedure is the most effective. The authors review...

The patient journey in DIEP flap breast reconstruction

In the UK approximately 40,000 women are diagnosed with breast cancer every year. About 40% of these need, or choose, to undergo mastectomy, where all of the breast tissue is removed. Currently around a third of these patients choose to...

Immediate versus delayed post mastectomy breast reconstruction

The authors review and analyse the current literature comparing the psychosocial outcomes of immediate versus delayed post mastectomy breast reconstruction. Breast cancer is the most prevalent cancer in women and has a lifetime incidence of one in nine. Mastectomy may...

We need to talk about amputation – a difficult conversation in the developing world

What do you do when a patient refuses amputation? The author shares various cases and outlines her team’s approach to this scenario in Gaza. What to do when a patient refuses amputation for a severely damaged lower limb that will...

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...